Charles River Laboratories (CRL) Tops Q4 EPS by 4c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mail
Get Alerts CRL Hot Sheet
Price: $359.41 -4.44%
Revenue Growth %: -4.0%
Financial Fact:
Discontinued operations (in dollars per share): 0.01
Today's EPS Names:
SYRS, ZVOI, OMID, More
Revenue Growth %: -4.0%
Financial Fact:
Discontinued operations (in dollars per share): 0.01
Today's EPS Names:
SYRS, ZVOI, OMID, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q4 EPS of $2.39, $0.04 better than the analyst estimate of $2.35. Revenue for the quarter came in at $994.2 million versus the consensus estimate of $987.2 million.
GUIDANCE:
Charles River Laboratories sees FY2026 EPS of $10.70-$11.20, versus the consensus of $10.89.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Texas Capital Securities Downgrades Full House Resorts (FLL) to Hold
- Citi cuts TFI International price target to $123 after earnings miss
- Franklin BSP Realty Trust (FBRT) PT Lowered to $10 at B.Riley
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
